Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01499563
Show Display Options
Rank Status Study
1 Completed Study of a Novel Antipsychotic ITI-007 in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: ITI-007;   Drug: Placebo;   Drug: Risperidone

Study has passed its completion date and status has not been verified in more than two years.